Delivery Order SPE2DB22D1106-SPE2DB25FFJC4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $1,211.69. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 11, 2025, and performance to be executed from the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger federal contract portfolio...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $63,839.13 under a firm fixed price contract. This delivery order represents a competitive award with no set-aside designation and is expected to be completed by September 12, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Euflexxa 1% 20 mg/2 ml syringes with a ceiling value of $2,424.26. The award was made on September 4, 2025, with an ultimate completion date of September 5, 2025, utilizing firm fixed price pricing. This is a non-set-aside competitive award, and the place of performance is listed as Conshohocken, Pennsylvania, which is also the company's corporate headquarters location. The delivery order...
- The Defense Logistics Agency awarded a $3,090.60 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Euflexxa 1% 20 mg/2 ml syringes. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by May 7, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $7,690.32 to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes with a ceiling value of $2,454.88 under a firm fixed-price contract. This delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a small-value pharmaceutical supply transaction supporting federal medical procurement needs. The award was competitively awarded without set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $3,962.99 and an ultimate completion date of September 10, 2025. Euflexxa is a viscosupplement injection used to treat knee osteoarthritis pain. This is a firm fixed price delivery order with no set-aside designation, placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $23.6K delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 MG/2 ML syringes on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with DLA, leveraging the company's position as a critical distributor of medical products for federal healthcare systems. The award carries no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 mL syringes with a ceiling value of $6,754.59 on August 14, 2025. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and no set-aside designation was used. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,794.80, is a firm fixed-price delivery order for EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product. The ultimate completion date for this order is November 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFJC4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,287.75 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Euflexxa 1% 20 mg/2 ml syringes. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with a completion date of September 12, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems, fulfills this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. This delivery order exemplifies AmerisourceBergen's role as a primary pharmaceutical supplier to the federal government, leveraging its comprehensive IDC to supply medical commodities across multiple therapeutic domains. The company's portfolio of DLA contract awards demonstrates consistent capability in delivering both specialty medications and medical devices to support military healthcare operations worldwide. The relatively modest order value for Euflexxa, a viscosupplement injection used for osteoarthritis treatment, reflects the granular nature of medical supply procurement through the larger prime vendor contract vehicle, enabling the DLA to obtain specific pharmaceutical products on an as-needed basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/11/25 |